针对高血压和血脂异常患者的缬沙坦、氨氯地平、罗伐他汀和依折麦布固定剂量复方片剂的战略设计和临床评估

IF 5.3 4区 医学 Q1 PHARMACOLOGY & PHARMACY
Tae-Kwang Kim, Jeong-Eun Lee, Kyuho Jeong, Min-Jun Baek, Dahan Kim, Jun-Young Jeon, Sangyoung Lee, Dae-Duk Kim
{"title":"针对高血压和血脂异常患者的缬沙坦、氨氯地平、罗伐他汀和依折麦布固定剂量复方片剂的战略设计和临床评估","authors":"Tae-Kwang Kim, Jeong-Eun Lee, Kyuho Jeong, Min-Jun Baek, Dahan Kim, Jun-Young Jeon, Sangyoung Lee, Dae-Duk Kim","doi":"10.1007/s40005-023-00651-w","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":16702,"journal":{"name":"Journal of Pharmaceutical Investigation","volume":"122 49","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2023-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Strategic design and clinical evaluation of a fixed-dose combination tablet comprising valsartan, amlodipine, rosuvastatin and ezetimibe for patients with hypertension and dyslipidemia\",\"authors\":\"Tae-Kwang Kim, Jeong-Eun Lee, Kyuho Jeong, Min-Jun Baek, Dahan Kim, Jun-Young Jeon, Sangyoung Lee, Dae-Duk Kim\",\"doi\":\"10.1007/s40005-023-00651-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":16702,\"journal\":{\"name\":\"Journal of Pharmaceutical Investigation\",\"volume\":\"122 49\",\"pages\":\"\"},\"PeriodicalIF\":5.3000,\"publicationDate\":\"2023-12-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmaceutical Investigation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s40005-023-00651-w\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Investigation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40005-023-00651-w","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。
Strategic design and clinical evaluation of a fixed-dose combination tablet comprising valsartan, amlodipine, rosuvastatin and ezetimibe for patients with hypertension and dyslipidemia
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Pharmaceutical Investigation
Journal of Pharmaceutical Investigation Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
10.20
自引率
9.10%
发文量
49
期刊介绍: Journal of Pharmaceutical Investigation(J. Pharm. Investig.), the official journal of the Korean Society of Pharmaceutical Sciences and Technology, is an international, peer-reviewed journal that covers all pharmaceutical sciences, including engineering, regulatory, physicochemical, biological, and microbiological studies related to the conception, design, production, characterization and evaluation of pharmaceutical products and drug delivery systems. It is a bimonthly journal published in January, March, May, July, September, and November. All manuscript should be creative and informative for pharmaceutical scientists, and should contain advanced knowledge in clear and concise English. Articles in the following categories are published: Research articles, Notes, Information, and Reviews.(Formerly Journal of Korean Pharmaceutical Sciences: ISSN 0259-2347)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信